Clinical Trial Update: Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health [NA]

View source ↗

Summary

A clinical trial evaluating docosahexaenoic acid (DHA) supplementation in women with hypertension in pregnancy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension in Pregnancy

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hypertension in Pregnancy | NA | Status: WITHDRAWN